SONA Asset Management (US)’s Drugs Made In America Acquisition Corp Rights DMAAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$46.3K Buy
+387,276
New +$53K ﹤0.01% 346

Other funds holding DMAAR

SONA Asset Management (US)'s DMAAR Position: Q3 2026 in Review

SONA Asset Management (US) opened a new position in Drugs Made In America Acquisition Corp Rights (DMAAR) in Q3 2026: 387,276 shares worth $46.3K. The stake represents ﹤0.01% of the portfolio and ranks #346 among its holdings.

32 funds tracked by Wall St. Rank hold DMAAR as of Q3 2026.

  • SONA Asset Management (US) held 387,276 shares of Drugs Made In America Acquisition Corp Rights worth $46.3K as of Q3 2026.
  • Drugs Made In America Acquisition Corp Rights was a new SONA Asset Management (US) position in Q3 2026.
  • Drugs Made In America Acquisition Corp Rights made up ﹤0.01% of SONA Asset Management (US)'s portfolio in Q3 2026, its #346 holding.
  • 32 funds tracked by Wall St. Rank held Drugs Made In America Acquisition Corp Rights as of Q3 2026.

Based on SONA Asset Management (US)'s 13F filing for Q3 2026, filed 16 Nov 2026.